Lannett Co Inc Revenue 2006-2020 | LCI

Lannett Co Inc revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Lannett Co Inc Annual Revenue
(Millions of US $)
2019 $655
2018 $685
2017 $633
2016 $542
2015 $407
2014 $274
2013 $151
2012 $123
2011 $107
2010 $125
2009 $119
2008 $72
2007 $83
2006 $64
2005 $45
Lannett Co Inc Quarterly Revenue
(Millions of US $)
2020-03-31 $144
2019-12-31 $136
2019-09-30 $127
2019-06-30 $134
2019-03-31 $173
2018-12-31 $194
2018-09-30 $155
2018-06-30 $171
2018-03-31 $174
2017-12-31 $184
2017-09-30 $155
2017-06-30 $139
2017-03-31 $162
2016-12-31 $171
2016-09-30 $162
2016-06-30 $169
2016-03-31 $140
2015-12-31 $127
2015-09-30 $106
2015-06-30 $99
2015-03-31 $99
2014-12-31 $115
2014-09-30 $93
2014-06-30 $81
2014-03-31 $80
2013-12-31 $67
2013-09-30 $46
2013-06-30 $40
2013-03-31 $39
2012-12-31 $37
2012-09-30 $35
2012-06-30 $36
2012-03-31 $31
2011-12-31 $28
2011-09-30 $29
2011-06-30 $26
2011-03-31 $26
2010-12-31 $30
2010-09-30 $25
2010-06-30 $34
2010-03-31 $31
2009-12-31 $29
2009-09-30 $31
2009-06-30 $35
2009-03-31 $29
2008-12-31 $29
2008-09-30 $26
2008-06-30 $21
2008-03-31 $17
2007-12-31 $18
2007-09-30 $18
2007-06-30 $17
2007-03-31 $20
2006-12-31 $23
2006-09-30 $22
2006-06-30 $19
2006-03-31 $16
2005-12-31 $15
2005-09-30 $14
2005-06-30 $9
2005-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.250B $0.655B
Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.920B 41.95
Takeda Pharmaceutical (TAK) Japan $57.916B 10.09
Astellas Pharma (ALPMY) Japan $29.770B 15.08
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.008B 22.31
Catalent (CTLT) United States $13.659B 52.80
Grifols, S.A (GRFS) Spain $13.050B 15.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.669B 0.00
Neurocrine Biosciences (NBIX) United States $11.206B 43.38
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.253B 43.88
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.115B 10.14
United Therapeutics (UTHR) United States $5.067B 11.71
Arrowhead Pharmaceuticals (ARWR) United States $4.490B 490.22
Hypermarcas (HYPMY) Brazil $4.287B 15.77
Evotec AG (EVTCY) Germany $4.065B 109.55
Nektar Therapeutics (NKTR) United States $3.902B 0.00
FibroGen (FGEN) United States $3.729B 0.00
ChemoCentryx (CCXI) United States $3.359B 0.00
PTC Therapeutics (PTCT) United States $3.175B 0.00
Sage Therapeutics (SAGE) United States $2.585B 0.00
Cronos Group (CRON) Canada $2.477B 70.80
Taro Pharmaceutical Industries (TARO) Israel $2.457B 11.89
Pacira BioSciences (PCRX) United States $2.328B 47.65
Corcept Therapeutics (CORT) United States $1.798B 17.83
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.787B 0.00
Xencor (XNCR) United States $1.763B 0.00
Indivior (INVVY) United States $1.721B 21.36
USANA Health Sciences (USNA) United States $1.711B 16.12
Ironwood Pharmaceuticals (IRWD) United States $1.550B 11.86
Heron Therapeutics (HRTX) United States $1.532B 0.00
Akebia Therapeutics (AKBA) United States $1.425B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.395B 15.03
Revolution Medicines (RVMD) United States $1.388B 0.00
Zogenix (ZGNX) United States $1.340B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.276B 0.00
Karyopharm Therapeutics (KPTI) United States $1.152B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Esperion Therapeutics (ESPR) United States $1.091B 0.00
Tilray (TLRY) Canada $1.086B 0.00
VAXART, INC (VXRT) United States $0.970B 0.00
Translate Bio (TBIO) United States $0.968B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.954B 596.13
Altimmune (ALT) United States $0.902B 0.00
Endo (ENDP) Ireland $0.804B 1.25
BioCryst Pharmaceuticals (BCRX) United States $0.746B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.692B 0.00
Trillium Therapeutics (TRIL) Canada $0.613B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Radius Health (RDUS) United States $0.564B 0.00
Aerie Pharmaceuticals (AERI) United States $0.541B 0.00
Siga Technologies (SIGA) United States $0.535B 0.00
Flexion Therapeutics (FLXN) United States $0.517B 0.00
Molecular Templates (MTEM) United States $0.510B 0.00
TherapeuticsMD (TXMD) United States $0.505B 0.00
Ardelyx (ARDX) United States $0.505B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.497B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.478B 18.63
Crinetics Pharmaceuticals (CRNX) United States $0.467B 0.00
DURECT (DRRX) United States $0.454B 0.00
Ocular Therapeutix (OCUL) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.395B 0.00
Calithera Biosciences (CALA) United States $0.352B 0.00
Harpoon Therapeutics (HARP) United States $0.327B 0.00
IMV INC (IMV) Canada $0.318B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.310B 0.00
PROFOUND MEDICL (PROF) Canada $0.296B 0.00
OptiNose (OPTN) United States $0.295B 0.00
MEI Pharma (MEIP) United States $0.290B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.269B 0.00
Redhill Biopharma (RDHL) Israel $0.261B 0.00
CASI Pharmaceuticals (CASI) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.221B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
Taiwan Liposome (TLC) Taiwan $0.197B 0.00
Nivalis Therapeutics (ALPN) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 25.03
Onconova Therapeutics (ONTX) United States $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
Heat Biologics (HTBX) United States $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.90
Matinas Biopharma Holdings (MTNB) United States $0.161B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.139B 0.00
Xeris Pharmaceuticals (XERS) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Otonomy (OTIC) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
CTI BioPharma (CTIC) United States $0.107B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.106B 0.00
Biomerica (BMRA) United States $0.106B 0.00
Recro Pharma (REPH) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
MediWound (MDWD) Israel $0.102B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.094B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.091B 0.00
Hemispherx BioPharma (AIM) United States $0.091B 0.00
Lipocine (LPCN) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
CV Sciences (CVSI) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Sundial Growers (SNDL) Canada $0.064B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.059B 0.00
AgeX Therapeutics (AGE) United States $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.049B 0.00
IsoRay (ISR) United States $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.06
NovaBay Pharmaceuticals (NBY) United States $0.041B 0.00
Jaguar Animal Health (JAGX) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.73
Can-Fite Biopharma (CANF) Israel $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 34.71
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00